Literature DB >> 21943464

Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

P Patel1, C Horsfield, F Compton, J Taylor, G Koffman, J Olsburgh.   

Abstract

INTRODUCTION: This study examined the clinical indications and timing for native nephrectomy (NN), together with the associated pathological findings in transplant patients with autosomal dominant polycystic kidney disease (ADPKD) at our institute over a period of 20 years.
METHODS: A retrospective review was performed of ADPKD patients who had undergone both kidney transplantation and NN. Patients were identified from the kidney transplant database between 1988 and 2008 at Guy's and St Thomas' Hospital and the notes reviewed. All NN specimens were re-reviewed and reported according to current guidelines.
RESULTS: There were 157 kidney transplants performed for ADPKD (114 cadaveric and 43 living donor). Of these, 31 required NN (28 bilateral). The timing of NN was pre-transplant in 10 cases, at the time of the transplant in 1 case and post-transplant in 20 cases. The indications for NN were urinary tract infection (n=14, 45%), pain (n=12, 39%), tumour suspicion (n=3, 10%), haematuria (n=1, 3%) and space (n=1, 3%). Mortality in this NN series was 3%, with a 65% surgical morbidity rate. The length of hospital stay post-NN was significantly longer with open compared with laparoscopic techniques (p=0.003). There were two renal cell carcinomas (RCCs) in this series. Both patients presented with macroscopic haematuria (bilateral pT1a papillary RCCs in one case and a pT3b clear cell RCC in the other case). The incidence of RCC in this series of ADPKD transplant patients was 1.3%.
CONCLUSIONS: We have demonstrated that the majority of ADPKD patients do not require NN, with only 20% of our series undergoing this procedure. The timing of NN is variable and dictated by indication. NN was only required to make space for transplantation in one case (combined kidney and pancreas transplant). The main indications for NN were recurrent infection and pain, where NN can provide a successful outcome. Laparoscopic NN can be performed safely in patients with ADPKD. Haematuria in such patients should not be assumed to be of benign origin and requires exclusion of urinary tract malignancy as the incidence of RCC in this population is at least as common as in the general population.

Entities:  

Mesh:

Year:  2011        PMID: 21943464      PMCID: PMC3365458          DOI: 10.1308/003588411X582690

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  31 in total

Review 1.  Urinary tract infection in the renal transplant patient.

Authors:  Ruth M de Souza; Jonathon Olsburgh
Journal:  Nat Clin Pract Nephrol       Date:  2008-03-11

Review 2.  Renal cell carcinoma in dialysis patients with acquired renal cysts.

Authors:  I L Noronha; E Ritz; R Waldherr; G Stein; W Fassbinder
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

Review 3.  Epidemiologic aspects of renal cell carcinoma.

Authors:  Joseph K McLaughlin; Loren Lipworth; Robert E Tarone
Journal:  Semin Oncol       Date:  2006-10       Impact factor: 4.929

4.  Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease.

Authors:  M D Dunn; A J Portis; A M Elbahnasy; A L Shalhav; M Rothstein; E M McDougall; R V Clayman
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

5.  Combined report on regular dialysis and transplantation in Europe, VIII, 1977.

Authors:  A J Wing; F P Brunner; H Brynger; C Chantler; R A Donckerwolcke; H J Gurland; R A Hathway; C Jacobs; N H Selwood
Journal:  Proc Eur Dial Transplant Assoc       Date:  1978

6.  The prevalence of renal cell carcinoma diagnosed at autopsy.

Authors:  Steven R Mindrup; Jessica S Pierre; Laila Dahmoush; Badrinath R Konety
Journal:  BJU Int       Date:  2005-01       Impact factor: 5.588

7.  Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.

Authors:  Pascal Hajj; Sophie Ferlicot; Walid Massoud; Ayman Awad; Yacine Hammoudi; Bernard Charpentier; Antoine Durrbach; Stéphane Droupy; Gérard Benoît
Journal:  Urology       Date:  2009-07-18       Impact factor: 2.649

8.  [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].

Authors:  P Simon; J Y Le Goff; K S Ang; C Charasse; P Le Cacheux; G Cam
Journal:  Nephrologie       Date:  1996

9.  Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.

Authors:  John H Stewart; Gherardo Buccianti; Lawrence Agodoa; Ryszard Gellert; Margaret R E McCredie; Albert B Lowenfels; Alex P S Disney; Robert A Wolfe; Peter Boyle; Patrick Maisonneuve
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

10.  Renal adenomas: pathological differential diagnosis with malignant tumors.

Authors:  F Algaba
Journal:  Adv Urol       Date:  2008-10-08
View more
  23 in total

1.  Volume regression of native polycystic kidneys after renal transplantation.

Authors:  Yeonsoon Jung; María V Irazabal; Fouad T Chebib; Peter C Harris; Patrick G Dean; Mikel Prieto; Fernando G Cosio; Ziad M El-Zoghby; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

2.  Laparoscopic pretransplant nephrectomy with morcellation in autosomic-dominant polycystic kidney disease patients with end-stage renal disease.

Authors:  Anastasios D Asimakopoulos; Richard Gaston; Roberto Miano; Filippo Annino; Camille Mugnier; Lorenzo Dutto; Giuseppe Vespasiani; Enrico Spera; Jean-Luc Hoepffner; Thierry Piechaud
Journal:  Surg Endosc       Date:  2014-08-15       Impact factor: 4.584

3.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 4.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

Review 5.  Renal cancer in kidney transplanted patients.

Authors:  Giovanni M Frascà; Silvio Sandrini; Laura Cosmai; Camillo Porta; William Asch; Matteo Santoni; Chiara Salviani; Antonia D'Errico; Deborah Malvi; Emilio Balestra; Maurizio Gallieni
Journal:  J Nephrol       Date:  2015-07-23       Impact factor: 3.902

Review 6.  Current management of autosomal dominant polycystic kidney disease.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2015-09-06

Review 7.  Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy.

Authors:  Chrysoula Argyrou; Demetrios Moris; Spyridon Vernadakis
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

Review 8.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

9.  Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches.

Authors:  Thibaut Benoit; Benoit Peyronnet; Mathieu Roumiguié; Grégory Verhoest; Jean-Baptiste Beauval; Arnaud Delreux; Dominique Chauveau; Bernard Malavaud; Andréa Manunta; Michel Soulié; Pascal Rischmann; Karim Bensalah; Xavier Gamé
Journal:  World J Urol       Date:  2015-12-10       Impact factor: 4.226

10.  Live Donor Renal Transplant With Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease Is Feasible and Satisfactory at Long-term Follow-up.

Authors:  Sarwat B Ahmad; Brian Inouye; Michael S Phelan; Andrew C Kramer; Jay Sulek; Matthew R Weir; Rolf N Barth; John C LaMattina; Eugene J Schweitzer; David B Leeser; Silke V Niederhaus; Stephen T Bartlett; Jonathan S Bromberg
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.